Clinical Trials

Lymphoid

Lymphoma, Recurrence

NCT07621471 2026-06-02

IL-15 Enhanced NK Cell Therapy for Solid Tumors

Phase EARLY_PHASE1 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis

NCT07123662 2026-05-28

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Other hematologic neoplasm

Leukemia

NCT07196111 2026-05-28

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Phase EARLY_PHASE1 Withdrawn

Lymphoid

Burkitt Lymphoma, Lymphoma

NCT07205315 2026-05-27

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Classical hematologyLymphoidOther hematologic neoplasm

28 enrolled

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04541108 2026-05-22

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Phase EARLY_PHASE1 Active not recruiting

15 enrolled

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT06097962 2026-05-20

Safety and Efficacy of NK510 to Treat NSCLC

Phase EARLY_PHASE1 Active not recruiting

Thoracic

Pleural Effusion, Malignant

NCT06959563 2026-05-20

9vHPV-BCG

20 enrolled

Papillomavirus Infections

NCT07595237 2026-05-19

A IIT Study of 177Lu-DOTA-SNA040

GastrointestinalOther solid neoplasm

Advanced Solid Tumors (Such as Gastric Cancer)

NCT07597759 2026-05-19

Phase IIT Trial of SNA009

Phase EARLY_PHASE1 Completed

Colorectal Neoplasms

NCT07597772 2026-05-19

Preliminary Trial of SNA014 for Pancreatic Cancer

Pancreatic Neoplasms

NCT06400485 2026-05-18

AMT-676 in Patients With Advanced Solid Tumors

24 enrolled

Advanced Solid Tumors

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

28 enrolled

Cachexia

NCT07590856 2026-05-15

A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33

20 enrolled

Colorectal Neoplasms

NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

50 enrolled

Phase EARLY_PHASE1 Withdrawn

Solid Tumors

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

CNS

Central Nervous System Neoplasms

NCT06653010 2026-05-07

Wondercel-UWD1

Colorectal Neoplasms

NCT06653023 2026-05-07

Wondercel-UWD3

60 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT06662227 2026-05-07

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT06663046 2026-05-07

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Plasma cell

Multiple Myeloma

NCT06675513 2026-05-07

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

Colorectal Neoplasms

NCT05245058 2026-05-05

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

150 enrolled

Phase EARLY_PHASE1 Terminated

HER2-positive Advanced Solid Tumors

NCT06077903 2026-05-05

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

Adult

NCT07561437 2026-05-01

NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors

18 enrolled

Phase EARLY_PHASE1 Terminated

Advanced Solid Tumors

NCT06094426 2026-04-29

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

2 enrolled

Solid Tumor

NCT07468708 2026-04-29

The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

Phase EARLY_PHASE1 Terminated

Genitourinary

Prostatic Neoplasms

NCT06834542 2026-04-27

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

1 enrolled

Adult Gynecological Tumors

NCT07542379 2026-04-21

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

13 enrolled

Genitourinary

Prostatic Neoplasms

NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

105 enrolled

Solid Malignancies

NCT07033689 2026-04-03

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Pancreatic Neoplasms

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Solid Tumors

NCT07376642 2026-03-30

A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Lymphoid

Lymphoma, B-Cell

NCT07493135 2026-03-30

A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Completed

Plasma cell

Multiple Myeloma

NCT04480645 2026-03-24

CivaDerm(TM) Surface Therapy Pilot Study

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT07487597 2026-03-23

Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors

24 enrolled